Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complicated Skin and Structure Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT01219114
What this trial is testing

Safety and Efficacy Study of CUBICIN (Daptomycin) Under Conditions of Actual Use

Who this might be right for
Complicated Skin and Skin Structure Infections and Bacteremia Including Right-sided Endocarditis
AstraZeneca 200
Not applicableStudy completedNCT00488488
What this trial is testing

A Pharmacovigilance Evaluation And Assessment Of The Prescribing Practice For Tygacil In Usual Health Care Setting

Who this might be right for
Infection
Pfizer 1,028
Post-approval studies (Phase 4)Ended earlyNCT00463801
What this trial is testing

Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections

Who this might be right for
Staphylococcal Skin Infections
Novartis 52
Post-approval studies (Phase 4)Ended earlyNCT01104662
What this trial is testing

Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bacteremia in Renal Impairment

Who this might be right for
Complicated Skin and Skin Structure InfectionsS. Aureus BacteremiaRenal Impairment
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 92
Post-approval studies (Phase 4)Study completedNCT00488761
What this trial is testing

Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI

Who this might be right for
Skin Diseases, Infectious
Wyeth is now a wholly owned subsidiary of Pfizer 50
Large-scale testing (Phase 3)Study completedNCT00249197
What this trial is testing

The Safety and Effectiveness of Levofloxacin Compared to Ticarcillin/Clavulanate Alone or Followed by Amoxicillin/Clavulanate in the Treatment of Complicated Skin Infections

Who this might be right for
Skin Diseases, Bacterial
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 413
Large-scale testing (Phase 3)Study completedNCT00772447
What this trial is testing

China Registration Study in Patients With Skin Infections

Who this might be right for
Skin DiseasesInfectious
AstraZeneca 265
Large-scale testing (Phase 3)Study completedNCT00299520
What this trial is testing

Phase 3 Safety and Efficacy Study of I.V. Iclaprim v Linezolid in cSSSI (ASSIST-1)

Who this might be right for
Complicated Skin and Skin Structure Infection
Arpida AG
Not applicableStudy completedNCT01293435
What this trial is testing

Study Evaluating Management of Patients With Community-Acquired Pneumonia (CAP) or Complicated Skin Infections

Who this might be right for
Community Acquired Pneumonia (CAP)Complicated Skin and Skin Structures Infections (cSSSI)
AstraZeneca 4,035
Testing effectiveness (Phase 2)Study completedNCT03716024
What this trial is testing

Study the Efficacy and Safety of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)

Who this might be right for
Infectious Skin DiseaseBacterial Skin Disease
Paratek Pharmaceuticals Inc 234
Large-scale testing (Phase 3)Study completedNCT00210899
What this trial is testing

Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections

Who this might be right for
Skin Diseases, InfectiousSkin Diseases, BacterialStaphylococcal Skin Infections
Basilea Pharmaceutica 828
Testing effectiveness (Phase 2)Study completedNCT01128530
What this trial is testing

Efficacy and Safety Study of JNJ-32729463 for Treating Complicated Skin and Skin Structure Infections Compared to Linezolid (Zyvox)

Who this might be right for
Complicated Skin and Skin Structure Infections
Furiex Pharmaceuticals, Inc 161
Large-scale testing (Phase 3)Study completedNCT00402727
What this trial is testing

Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection

Who this might be right for
AbscessWound InfectionDiabetic Foot+1 more
Bayer 813
Large-scale testing (Phase 3)Ended earlyNCT00865280
What this trial is testing

Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)

Who this might be right for
Skin Diseases, Infectious
Paratek Pharmaceuticals Inc 143
Testing effectiveness (Phase 2)Study completedNCT00633152
What this trial is testing

Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections

Who this might be right for
Bacterial Infection
Forest Laboratories 150
Post-approval studies (Phase 4)Ended earlyNCT00102947
What this trial is testing

Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections

Who this might be right for
Soft Tissue Infections
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 72
Post-approval studies (Phase 4)Study completedNCT00087490
What this trial is testing

Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)

Who this might be right for
Skin/Soft Tissue InfectionsMethicillin Resistant Staphylococcus Aureus (MRSA)
Pfizer 1,077
Testing effectiveness (Phase 2)Study completedNCT00719810
What this trial is testing

Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections

Who this might be right for
Skin Structure InfectionsBacterial Skin DiseasesStaphylococcal Skin Infections
Melinta Therapeutics, Inc. 150
Not applicableStudy completedNCT00683332
What this trial is testing

Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)

Who this might be right for
Complicated Skin and Skin Structure InfectionsComplicated Intra-abdominal Infections
Pfizer 621
Testing effectiveness (Phase 2)Study completedNCT00514527
What this trial is testing

Patients With Complicated Skin and Skin Structure Infections

Who this might be right for
Staphylococcal Skin InfectionsWounds and InjuriesAbscess+2 more
Targanta Therapeutics Corporation 294
Next Page